Get the Stockscreener App
19.73
0.46%
0.09
After Hours:
19.73
Healthpeak Properties Inc stock is traded at $19.73, with a volume of 5.63M.
It is up +0.46% in the last 24 hours and up +20.82% over the past month.
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
See More
Previous Close:
$19.64
Open:
$19.75
24h Volume:
5.63M
Relative Volume:
0.68
Market Cap:
$13.60B
Revenue:
$2.87B
Net Income/Loss:
$250.10M
P/E Ratio:
61.89
EPS:
0.3188
Net Cash Flow:
$1.13B
1W Performance:
+1.91%
1M Performance:
+20.82%
6M Performance:
+10.59%
1Y Performance:
+17.30%
1-Day Range:
$19.61
$19.89
1-Week Range:
$19.20
$19.89
52-Week Range:
$15.70
$19.91
Healthpeak Properties Inc Stock (DOC) Company Profile
Name
Healthpeak Properties Inc
Sector
Industry
Phone
949-407-0700
Address
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, CTRE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
19.73 | 13.54B | 2.87B | 250.10M | 1.13B | 0.3188 |
WELL
Welltower Inc
|
216.17 | 152.48B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
88.18 | 42.78B | 6.13B | 272.21M | 1.38B | 0.5521 |
OHI
Omega Healthcare Investors Inc
|
47.90 | 14.37B | 1.24B | 655.98M | 857.80M | 2.063 |
CTRE
Caretrust Reit Inc
|
41.14 | 9.69B | 522.75M | 333.94M | 397.14M | 1.5617 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-20-26 | Initiated | UBS | Neutral |
| Feb-05-26 | Downgrade | Argus | Buy → Hold |
| Jan-09-26 | Initiated | Goldman | Neutral |
| Dec-16-25 | Downgrade | Jefferies | Buy → Hold |
| Oct-01-25 | Initiated | Cantor Fitzgerald | Neutral |
| Sep-15-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-29-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Jan-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-21-24 | Upgrade | Deutsche Bank | Hold → Buy |
| May-03-24 | Upgrade | Wedbush | Neutral → Outperform |
| Apr-26-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Apr-22-24 | Resumed | Mizuho | Buy |
| Apr-01-24 | Upgrade | BofA Securities | Underperform → Buy |
| Mar-25-24 | Resumed | Wells Fargo | Equal Weight |
| Mar-08-24 | Resumed | RBC Capital Mkts | Outperform |
| Jan-05-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-26-23 | Initiated | JMP Securities | Mkt Outperform |
| Apr-20-23 | Initiated | Wells Fargo | Underweight |
| Dec-14-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Oct-28-22 | Initiated | JP Morgan | Neutral |
| Aug-05-22 | Downgrade | Colliers Securities | Buy → Neutral |
| Jun-03-22 | Initiated | CapitalOne | Equal Weight |
| May-19-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Apr-26-22 | Initiated | Barclays | Overweight |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-07-22 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-13-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-20-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jun-14-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-15-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-13-21 | Upgrade | Jefferies | Hold → Buy |
| Dec-14-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Nov-11-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-30-20 | Resumed | Robert W. Baird | Outperform |
| Sep-02-20 | Resumed | Stifel | Buy |
| Apr-07-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-01-20 | Upgrade | Berenberg | Hold → Buy |
| Mar-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-09-20 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Feb-27-20 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Dec-20-19 | Initiated | Mizuho | Buy |
| Dec-12-19 | Upgrade | Citigroup | Neutral → Buy |
| Nov-26-19 | Upgrade | Stifel | Hold → Buy |
| Oct-14-19 | Initiated | BofA/Merrill | Neutral |
| Jun-20-19 | Initiated | Citigroup | Neutral |
| May-02-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Aug-03-18 | Upgrade | CapitalOne | Equal Weight → Overweight |
| Apr-25-18 | Downgrade | Stifel | Buy → Hold |
| Mar-01-18 | Reiterated | B. Riley FBR, Inc. | Buy |
| Jan-05-18 | Reiterated | Robert W. Baird | Outperform |
| Nov-06-17 | Upgrade | Hilliard Lyons | Long-term Buy → Buy |
View All
Healthpeak Properties Inc Stock (DOC) Latest News
Healthpeak Properties (DOC) Gains Momentum with Positive Market Trends - GuruFocus
Healthpeak Properties stock: Is DOC underperforming the real estate sector? - MSN
Morgan Stanley Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Healthpeak Properties Is Maintained at Overweight by Morgan Stanley - Moomoo
Healthpeak Properties Price Target Raised to $20.00/Share From $18.00 by Morgan Stanley - Moomoo
DOC Maintained by Morgan Stanley -- Price Target Raised to $20 - GuruFocus
Morgan Stanley Adjusts Price Target on Healthpeak Properties to $20 From $18, Maintains Overweight Rating - Moomoo
What is Janus Living and Why is Healthpeak Spinning it Off - Kavout
A Look At Healthpeak Properties (DOC) Valuation After Strong Recent Share Price Momentum - Yahoo Finance
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Healthpeak’s S&P 500 Rally Raises A Big Valuation Question - Kalkine Media
Analysts Offer Insights on Real Estate Companies: Rayonier (RYN), Weyerhaeuser (WY) and Healthpeak Properties (DOC) - The Globe and Mail
Assessing Healthpeak Properties (DOC) Valuation After Recent Share Price Momentum - simplywall.st
Verizon and 4 More Stocks With 5% Dividend Yields—and Market-Beating Returns - Barron's
Mizuho Securities Maintains Healthpeak Properties(DOC.US) With Buy Rating, Raises Target Price to $21 - Moomoo
New York Life Investment Management LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak (DOC) CEO makes 120,372-unit OP equity gifts, retains stake - Stock Titan
How Investors Are Reacting To Healthpeak Properties (DOC) Earnings Upgrade And Completed Share Buyback - simplywall.st
Are Wall Street analysts bullish on Healthpeak Properties stock? - MSN
Verizon and 4 Other Stocks With 5% Yields—and Market-Beating Returns - Barron's
Baird Raises its Price Target on Healthpeak Properties (DOC) - Insider Monkey
Mizuho Adjusts Price Target on Healthpeak Properties to $21 From $18, Maintains Outperform Rating - Moomoo
JAN Stock Price, Quote & Chart | JANUS LIVING INC CL-A-1 (NYSE:JAN) - ChartMill
Healthpeak Properties stock (US42226K1051): analyst moves and solid earnings support 2026 rally - AD HOC NEWS
10 Fastest Growing S&P 500 Stocks to Buy Now - Insider Monkey
Healthpeak Properties, Inc.: - marketscreener.com
Healthpeak Properties Q1 earnings call highlights - MSN
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
BNP Paribas Adjusts PT on Healthpeak Properties to $22 From $21, Maintains Outperform Rating - Moomoo
[SCHEDULE 13G] Janus Living, Inc. Passive Investment Disclosure (>5%) - Stock Titan
DOC Maintained by RBC Capital -- Price Target Raised to $21.00 - GuruFocus
Healthpeak Properties Is Maintained at Outperform by RBC Capital - Moomoo
Healthpeak Properties (NYSE:DOC) Hits New 1-Year High After Analyst Upgrade - MarketBeat
RBC Raises Price Target on Healthpeak Properties to $21 From $20, Keeps Outperform Rating - marketscreener.com
VIRGINIA RETIREMENT SYSTEMS ET Al Has $5.15 Million Position in Healthpeak Properties, Inc. $DOC - MarketBeat
Healthpeak Properties: A Healthy Balance Sheet And Growth Opportunities Outweigh Risk Concerns - Seeking Alpha
Insider Sell: Scott Bohn Sells Shares of Healthpeak Properties I - GuruFocus
Scott Bohn Sells 10,989 Shares of Healthpeak Properties (NYSE:DOC) Stock - MarketBeat
Healthpeak Properties Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Healthpeak (NYSE: DOC) CDO Scott Bohn sells 10,989 shares - Stock Titan
DOC Maintained by UBS -- Price Target Raised to $19.00 - GuruFocus
JPMorgan Chase (DOC) holds 43.09M shares, 6.1% stake in Healthpeak (05/13/2026) - Stock Titan
UBS Raises Healthpeak Properties Price Target to $19 From $17, Neutral Rating Kept - marketscreener.com
DOC Maintained by Baird -- Price Target Raised to $21.00 - GuruFocus
Healthpeak Properties stock (US42226K1051): Baird, Citi and Jefferies raise price targets - AD HOC NEWS
Jefferies Adjusts Price Target on Healthpeak Properties to $19 From $16, Maintains Hold Rating - marketscreener.com
Baird Adjusts Price Target on Healthpeak Properties to $21 From $19, Maintains Outperform Rating - marketscreener.com
Healthpeak Properties: Lab Weakness Creates A Major Re-Rating Opportunity (NYSE:DOC) - Seeking Alpha
DOC Maintained by Citigroup -- Price Target Raised to $20.00 - GuruFocus
[144] HEALTHPEAK PROPERTIES, INC. SEC Filing - Stock Titan
Evercore ISI Downgrades Healthpeak Properties to In Line From Outperform, Adjusts Price Target to $21 From $20 - Moomoo
Healthpeak Properties Inc Stock (DOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.75%
0.32%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):